118 related articles for article (PubMed ID: 14512789)
1. Identification of the immunodominant regions of the melanoma antigen tyrosinase by anti-tyrosinase monoclonal antibodies.
Jaanson N; Möll K; Kulla A; Ustav M
Melanoma Res; 2003 Oct; 13(5):473-82. PubMed ID: 14512789
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
[TBL] [Abstract][Full Text] [Related]
3. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis.
Willers J; Lucchese A; Mittelman A; Dummer R; Kanduc D
Exp Dermatol; 2005 Jul; 14(7):543-50. PubMed ID: 15946243
[TBL] [Abstract][Full Text] [Related]
4. Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient.
Kobayashi H; Kokubo T; Takahashi M; Sato K; Miyokawa N; Kimura S; Kinouchi R; Katagiri M
Immunogenetics; 1998 Apr; 47(5):398-403. PubMed ID: 9510558
[TBL] [Abstract][Full Text] [Related]
5. Murine tyrosinase expressed by a T7 vector in bone marrow-derived dendritic progenitors effectively prevents and eradicates melanoma tumors in mice.
Li J; Holmes LM; Franek KJ; Wagner TE; Wei Y
Cancer Gene Ther; 2000 Nov; 7(11):1448-55. PubMed ID: 11129287
[TBL] [Abstract][Full Text] [Related]
6. Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase.
Riley JP; Rosenberg SA; Parkhurst MR
J Immunother; 2001; 24(3):212-20. PubMed ID: 11394498
[TBL] [Abstract][Full Text] [Related]
7. Epitope mapping of SCLC-cluster-2 MAbs and generation of antibodies directed against new EGP-2 epitopes.
Helfrich W; Koning PW; The TH; De Leij L
Int J Cancer Suppl; 1994; 8():64-9. PubMed ID: 7515032
[TBL] [Abstract][Full Text] [Related]
8. Identification of epitopes on cytochrome P450 3A4/5 recognized by monoclonal antibodies.
Parimoo B; Mishin VM; Busch CM; Thomas PE
Arch Biochem Biophys; 2003 Jun; 414(2):244-54. PubMed ID: 12781776
[TBL] [Abstract][Full Text] [Related]
9. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development.
Kittlesen DJ; Thompson LW; Gulden PH; Skipper JC; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH; Slingluff CL
J Immunol; 1998 Mar; 160(5):2099-106. PubMed ID: 9498746
[TBL] [Abstract][Full Text] [Related]
10. MAT-1, a monoclonal antibody that specifically recognizes human tyrosinase.
Takimoto H; Suzuki S; Masui S; Shibata K; Tomita Y; Shibahara S; Nakano H
J Invest Dermatol; 1995 Dec; 105(6):764-8. PubMed ID: 7490469
[TBL] [Abstract][Full Text] [Related]
11. Detection of mouse tyrosinase with a monoclonal antibody MAT-1 against human tyrosinase.
Suzuki S; Takimoto H; Masui S; Kato T; Shibata K; Tomita Y; Shibahara S; Nakano H
Pigment Cell Res; 1996 Dec; 9(6):298-303. PubMed ID: 9125753
[TBL] [Abstract][Full Text] [Related]
12. Development, characterization, and epitope mapping of a panel of twenty-four monoclonal antibodies specific for human inducible nitric oxide synthase.
Webber RJ; Rodriguez JG; Webber DS; Dunnebacke TH
Hybridoma (Larchmt); 2005 Feb; 24(1):6-13. PubMed ID: 15785204
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells.
Nicholson LB; Vlase H; Graves P; Nilsson M; Molne J; Huang GC; Morgenthaler NG; Davies TF; McGregor AM; Banga JP
J Mol Endocrinol; 1996 Apr; 16(2):159-70. PubMed ID: 9156519
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
Babas T; Le Grand R; Dormont D; Bahraoui E
AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816
[TBL] [Abstract][Full Text] [Related]
15. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies produced against murine tyrosinase identify pigmented human melanocytes.
Tomita Y; Hearing VJ
Diagn Immunol; 1986; 4(3):149-54. PubMed ID: 3089671
[TBL] [Abstract][Full Text] [Related]
17. Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
J Invest Dermatol; 1999 Aug; 113(2):267-71. PubMed ID: 10469315
[TBL] [Abstract][Full Text] [Related]
18. Coordinated mRNA and protein expression of human LAMP-1 in induction of melanogenesis after UV-B exposure and co-transfection of human tyrosinase and TRP-1 cDNAs.
Jimbow K; Luo D; Chen H; Hara H; Lee MH
Pigment Cell Res; 1994 Oct; 7(5):311-9. PubMed ID: 7886004
[TBL] [Abstract][Full Text] [Related]
19. Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease.
Paley EL; Smelyanski L; Malinovskii V; Subbarayan PR; Berdichevsky Y; Posternak N; Gershoni JM; Sokolova O; Denisova G
Mol Immunol; 2007 Jan; 44(4):541-57. PubMed ID: 16616781
[TBL] [Abstract][Full Text] [Related]
20. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
Topalian SL; Rivoltini L; Mancini M; Markus NR; Robbins PF; Kawakami Y; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9461-5. PubMed ID: 7937789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
